According to the report, the global oligonucleotide synthesis market was valued at US$ 1,966.2 Mn in 2021 and is anticipated to expand at a CAGR of 9.5% from 2022 to 2030
According to the report, the global oligonucleotide synthesis market was valued at US$ 1,966.2 Mn in 2021 and is anticipated to expand at a CAGR of 9.5% from 2022 to 2030
Technological advancements in synthetic chemistry to Drive Global Oligonucleotide Synthesis: Key Drivers
The advances in the technological development of organic molecules are expected to drive the growth of the oligonucleotide synthesis market
Download Sample @ https://qyresearchmedical.com/sample/111632
The advanced synthesis of oligonucleotides provides longer oligos with better sequence fidelity and higher purity that can be used in a number of molecular biology applications
Various pharmaceutical and biotechnology companies are continuously working on developing newer and advanced methods in synthetic chemistry
For instance, Integrated DNA Technologies, leader of synthesized oligonucleotides has developed various pioneered methods to synthesize oligonucleotides of extreme lengths. The company has developed oligonucleotides up to 200 base length which is used with mass spectrometry for the manufacture of mini-genes.
Get a glimpse of the in-depth analysis through our Report Brochure
Increasing use of Synthesized Oligonucleotides in Diagnostics and Research Applications Boost Market Growth
Oligonucleotides have a wide range of applications in areas such as molecular biology, biotechnology, and diagnosis
Natural oligonucleotides have been extensively used for the selection and determination of DNA sequences (hybridization probes or affinity purification), gene construction, and site-directed mutagenesis
They constitute the basic reagents for PCR technologies. They are also used to selectively inhibit gene expression in in vitro studies for diagnostic purpose and more recently, their ability to interact with proteins has generated immense opportunity for therapeutic use.
Along with diagnostics, they are widely used in research studies. Combinatorial technology is another research area where oligonucleotides and their analogs are extensively employed.
Limitations in the Synthesis of Oligonucleotides to Hamper Market
An oligonucleotide is a single-stranded chain consisting of a number of nucleoside units linked together by phosphodiester bridges
Mostly in oligonucleotide synthesis, phosphodiesters are formed between a 3’-hydroxyl group bearing a phosphate derivative and a 5’-hydroxyl group of another nucleoside
The occurrence of side reactions sets practical limits for the length of synthetic DNA oligonucleotides (up to about 200 nucleotide residues) because the number of errors accumulates with the length of the oligonucleotide being synthesized
To synthesize RNA with longer nucleotides base, that is more than 50 nucleotides is very complex and difficult to prepare
But, most biologically important RNA molecules such as ribozymes, aptamers, and riboswitches are significantly longer than 50 nucleotides, so new approaches for the synthesis of RNA analogs are urgently required
Global Oligonucleotide Synthesis Market: Competitive Landscape
This report profiles major players in the global oligonucleotide synthesis market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
The global oligonucleotide synthesis market is highly fragmented, with the presence of a number of international as well as regional players
Leading players operating in the global Oligonucleotide Synthesis market are
- GE Healthcare
- Thermo Fischer Scientific
- Agilent Technologies, Inc.
- Merck KGaA
- Integrated DNA Technologies, Inc.
- Kaneka Eurogentec S.A
- BioAutomation
- Gene Design, Inc.
- Eurofins Genomics
- ATDBio, Ltd..
Global Oligonucleotide Synthesis Market: Key Developments
Key players in the global oligonucleotide synthesis market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global oligonucleotide synthesis market. A few expansion strategies adopted by players operating in the global oligonucleotide Synthesis market are:
In May 2017, GE Healthcare announced the launch of its Superdex 30 Increase, a new generation column resin for small-scale preparative purification and analysis, adding another product to the already existing wide portfolio of Superdex Increase family of SEC columns.
The report on the global oligonucleotide synthesis market discussed individual strategies, followed by company profiles of manufacturers of oligonucleotide synthesis. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global oligonucleotide synthesis market.
Key Questions Answered in Global Oligonucleotide Synthesis Market Report
- What is the scope of growth of product companies in the global oligonucleotide synthesis market?
- What will be the Y-o-Y growth of the global oligonucleotide synthesis market between 2019 and 2027?
- What is the influence of changing trends in technologies on the global oligonucleotide synthesis market?
- Will North America continue to be the most profitable market for oligonucleotide synthesis providers?
- Which factors are anticipated to hamper the growth of the global oligonucleotide synthesis market during the forecast period?
- Which are the leading companies in the global oligonucleotide synthesis market?
Global Oligonucleotide Synthesis Market – Segmentation
Product Product Type
- Reagents & Consumables
- Equipment
- Synthesized Oligonucleotides
- DNA
- RNA
- Others
Applications
- Research
- Polymerase Chain Reaction
- Next Generation Sequencing
- Others
- Therapeutics
- Antisense Oligonucleotides
- Nucleic Acid Aptamers
- Diagnostic
End User
- Biotech & Pharma Companies
- Research Inst.
- Diagnostic Labs
Region
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/111632/2900
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
About Us
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/